[HTML][HTML] ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

Q Liu, C Lv, Q Huang, L Zhao, X Sun, D Ning… - Cell Death …, 2022 - nature.com
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway.

Q Liu, C Lv, Q Huang, L Zhao, X Sun… - Cell Death …, 2022 - search.ebscohost.com
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway.

Q Liu, C Lv, Q Huang, L Zhao, X Sun, D Ning… - Cell Death …, 2022 - europepmc.org
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

Q Liu, C Lv, Q Huang, L Zhao, X Sun, D Ning, J Liu… - Cell Death …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Hair follicle-derived mesenchymal stem cells
(HF-MSCs) show considerable therapeutic potential for liver cirrhosis (LC). To improve the …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

Q Liu, L Chengqian, Q Huang, L Zhao… - Cell Death …, 2022 - search.proquest.com
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

Q Liu, C Lv, Q Huang, L Zhao, X Sun… - Cell death …, 2022 - pubmed.ncbi.nlm.nih.gov
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

[HTML][HTML] ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

Q Liu, C Lv, Q Huang, L Zhao, X Sun, D Ning… - Cell Death …, 2022 - ncbi.nlm.nih.gov
Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway.

Q Liu, C Lv, Q Huang, L Zhao, X Sun, D Ning… - Cell Death …, 2022 - europepmc.org
Liver cirrhosis (LC) is induced by a variety of causes, including infectious factors, chemical
injury, and metabolic and genetic factors. There is no effective way to cure LC except for …